The HogenEsch Research Group
Our research focuses on vaccine development and mechanisms of chronic inflammation for the benefit of people and animals.
Franco J, Rajwa B, Ferreira C, Sundberg JP, HogenEsch H (2020) Influence of sex and disease stage on epidermal lipid profiles in SHARPIN-deficient mice. Metabolites, 10:299.
Hernandez-Franco J, Mosley YC, Franco J, Ragland D, Yao Y, HogenEsch H (2021) Effective and safe stimulation of humoral and cell-mediated immunity by intradermal immunization with a cyclic dinucleotide/nanoparticle combination adjuvant. J Immunol, 206: 700-711.
Mosley YC, Radder JE, HogenEsch H (2019) Genetic variation in the magnitude and longevity of the IgG subclass response to a Diphtheria-Tetanus-acellular Pertussis (DTaP) vaccine in mice. Vaccines, 7:124.
Lu F, Mosley YC, Brown D, Carmichael B, HogenEsch H (2019) Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response. Vaccine, 37:1945-1953.
- Purdue Institute of Inflammation, Immunology, and Infectious Diseases
- Bindley Bioscience Center
- Bioinformatics Core Facilty
- Center for Comparative Translational Research
- American Association of Immunologists
- American College of Veterinary Pathologists
- Mouse Genome Informatics